Watch STEK. Know when insiders buy.
One email the day a filing lands. Free.
STEK
Stemtech Corp
0.00
+0.00 +0.00%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $300KP/E —DIV YIELD —FCF YIELD -109.69%REV TTM $2.4M −38.6%NET INCOME −$3.8MNET DEBT $4.1M52W 0.00 – 0.01SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $629K | −9.8% | 74.0% | −$126K | −$292K | — | 0.00 | −$55K | $0 | −$55K | Aug 14 |
| Q1 2026 · Mar 31 | $463K | −46.7% | 76.4% | −$1.1M | −$1.3M | — | 0.00 | −$426K | $0 | −$426K | Jun 22 |
| Q4 2025 · Dec 31derived | $458K | −65.1% | 77.4% | −$864K | −$1.5M | — | 0.00 | $127K | $0 | $127K | Aug 14 |
| Q3 2025 · Sep 30 | $852K | −17.4% | 80.1% | −$339K | −$809K | — | -0.01 | $25K | $0 | $25K | Nov 19 |
| Q2 2025 · Jun 30 | $698K | −47.4% | 79.1% | −$301K | −$293K | — | 0.00 | $75K | $0 | $75K | Aug 14 |
| Q1 2025 · Mar 31 | $868K | −37.2% | 83.0% | −$1.2M | −$1.5M | — | -0.01 | −$711K | $0 | −$711K | Jun 22 |
| Q4 2024 · Dec 31derived | $1.3M | −3.5% | 79.6% | $33K | −$397K | — | 0.00 | −$271K | $0 | −$271K | Aug 14 |
| Q3 2024 · Sep 30 | $1M | −20.5% | 63.1% | −$716K | −$1.2M | — | -0.01 | −$1.2M | $0 | −$1.2M | Nov 19 |
| Q2 2024 · Jun 30 | $1.3M | — | 74.9% | −$692K | −$784K | — | -0.01 | −$176K | $0 | −$176K | Aug 19 |
| Q1 2024 · Mar 31 | $1.4M | — | 75.0% | −$1M | −$1.4M | — | -0.02 | $1M | $0 | $1M | Jul 17 |
| Q4 2023 · Dec 31derived | $1.4M | — | 83.9% | −$1.4M | −$1.9M | — | -0.02 | −$1.1M | — | — | Aug 14 |
| Q3 2023 · Sep 30 | $1.3M | — | 77.6% | −$579K | −$1M | — | -0.01 | −$5K | — | — | Dec 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.9M | 80.3% | −$2.7M | −$4M | -140.7% | -0.02 | −$484K | $0 | −$484K | — | — |
| FY2024 · to Dec 31 | $5.1M | 73.8% | −$2.4M | −$3.8M | -74.6% | -0.03 | −$601K | $0 | −$601K | — | — |
| FY2023 · to Dec 31 | $4.9M | 79.6% | −$4.2M | −$5.4M | -110.3% | -0.07 | −$2M | $0 | −$2M | — | — |
| FY2022 · to Dec 31 | $4.6M | 74.5% | −$5M | −$8.5M | -187.4% | -0.19 | −$1.2M | — | — | — | — |
| FY2021 · to Dec 31 | $4.3M | 76.3% | −$3.2M | −$7.1M | -163.8% | -0.20 | −$1.9M | — | — | — | — |
| FY2020 · to Dec 31 | $4.4M | 83.7% | −$1.4M | −$917K | -20.9% | -0.10 | −$267K | $12K | −$278K | — | — |
Every number comes from Stemtech Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.